International Clinical Trial: Efficacy and Safety of Transarterial Chemoembolization Followed by Continuous Infusion Chemotherapy Combined with Bevacizumab Biosimilar and Sintilimab (the THBS Quadruple Regimen) for Unresectable Hepatocellular Carcinoma with High Tumor Burden: A Prospective Multicenter Exploratory Study

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114805) titled 'Efficacy and Safety of Transarterial Chemoembolization Followed by Continuous Infusion Chemotherapy Combined with Bevacizumab Biosimilar and Sintilimab (the THBS Quadruple Regimen) for Unresectable Hepatocellular Carcinoma with High Tumor Burden: A Prospective Multicenter Exploratory Study' on Dec. 17, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: First Affiliated Hospital of the Army Medical University of the Chinese People's Liberation Army

Condition: hepatocellular carcinoma

Intervention: single-arm study:After screening, patients promptly underwent supplementary exami...